New ‘No Touch’ Protocols for EMA from the USA

7 April 2020

Details are provided here of an EMA protocol from US experts soon to be published in the journal Contraception. The protocol is in draft form; however, the authors do not expect much in the way of changes. This protocol is very similar to what is currently being implemented at BPAS.

Sample Protocol and Patient Instructions for No-Test Medication Abortion – Draft 3 April 2020

Sample Protocol and Patient Instructions for No-Test Medication Abortion – Draft 3 April 2020

Currently under review by Contraception; the journal’s editor has authorized distribution in advance of publication.

Protocol Purpose: To enable safe and effective provision of medication abortion without a mandatory pre-treatment ultrasound, pelvic examination or laboratory tests when medically appropriate, given that these tests may be significant barriers to access and, in the setting of a pandemic, may increase transmission of infection to patients and health care workers.

 

The Reproductive Health Access Project have also made protocols for ‘no touch’ EMA as well as miscarriage and ectopic pregnancy assessment available at the following link:

https://www.reproductiveaccess.org/covid19/

 

These protocols, together with other useful information relating to COVID-19, are available on the ‘open access’ ‘COVID-19 Advice’ page within the ‘Resources’ section on the BSACP website. Direct link: https://bsacp.org.uk/resources/covid-19-advice/

 

Dr Patricia Lohr

BPAS Medical Director/BSACP Education Officer